 |
市場調査レポート
商品コード
1379133
デジタル糖尿病管理市場レポート：製品タイプ、デバイスタイプ、地域別、2023-2028年Digital Diabetes Management Market Report by Product Type (Smart Glucose Meter, Smart Insulin Pumps, Smart Insulin Pens, Apps), Device Type (Handheld Devices, Wearable Devices), and Region 2023-2028 |
||||||
● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。 詳細はお問い合わせください。
| デジタル糖尿病管理市場レポート：製品タイプ、デバイスタイプ、地域別、2023-2028年 |
|
出版日: 2023年11月02日
発行: IMARC
ページ情報: 英文 139 Pages
納期: 2～3営業日
|
- 全表示
- 概要
- 図表
- 目次
概要
世界のデジタル糖尿病管理市場規模は2022年に108億米ドルに達しました。今後、IMARC Groupは、同市場が2022年から2028年の間に22.2%の成長率（CAGR）を示し、2028年までに360億米ドルに達すると予測しています。糖尿病有病率の上昇、大幅な技術進歩、患者中心のケアへのシフト、有利な政府のイニシアチブ、AIの統合、遠隔医療および遠隔患者モニタリングソリューションの採用増加、戦略的提携は、市場を推進する主な要因の一部です。
デジタル糖尿病管理とは、個人の糖尿病状態のモニタリングとコントロールを支援する技術とデジタルソリューションの活用を指します。これらのデジタルツールやアプリケーションは、血糖値、服薬アドヒアランス、身体活動、食事摂取量の追跡を支援する様々な機能を提供します。スマートフォン、ウェアラブルデバイス、クラウドベースのプラットフォームを活用することで、デジタル糖尿病管理はリアルタイムのデータ収集と分析を可能にし、患者のより良い自己管理と関与を促進します。デジタル糖尿病管理の主な利点のひとつは、収集されたデータに基づいてパーソナライズされた洞察と実用的な推奨を提供できることです。これにより、患者はライフスタイルの選択や治療計画について、十分な情報に基づいた意思決定を行うことができます。さらに、ヘルスケアプロバイダーは患者の健康状態を包括的に把握することができるため、必要に応じて遠隔モニタリングやタイムリーな介入を行うことができます。さらに、これらのテクノロジーは、インタラクティブな機能や教育リソースを通じて継続的な関与と動機付けを促進することで、患者の転帰改善に貢献します。また、患者とヘルスケア専門家間のシームレスなコミュニケーションを促進し、全体的なケア体験を向上させます。
世界の糖尿病罹患率の上昇により、糖尿病を管理するための効果的で便利なソリューションに対する大きな需要が生まれています。デジタル糖尿病管理ツールは、リアルタイムのモニタリングと個別ケアを提供するため、患者にとってもヘルスケアプロバイダーにとっても魅力的な選択肢となっています。さらに、糖尿病治療において患者のエンパワーメントと自己管理が重視されるようになってきています。デジタル糖尿病管理ソリューションは、情報への容易なアクセス、個別化された洞察、モニタリングとアドヒアランスのためのツールを提供することで、患者が自分の健康を管理する力を与えます。この他にも、人工知能や機械学習アルゴリズムをデジタル糖尿病管理プラットフォームに統合することで、予測分析やパーソナライズされた推奨が可能になりました。これらの技術は治療計画と介入を強化し、市場の需要を促進しています。このほか、遠隔医療や遠隔患者モニタリング・ソリューションの採用が増加していることも、デジタル糖尿病管理ツールの需要をさらに押し上げています。これらの技術は、ヘルスケアプロバイダーが患者の健康を遠隔監視し、必要に応じて介入することを可能にし、患者のケアと利便性を向上させる。これに伴い、同市場ではデジタルヘルス企業と製薬企業との提携が進み、糖尿病管理ソリューションと投薬・治療レジメンとの統合が進んでいます。このような提携は、市場範囲を拡大し、製品提供を強化します。さらに、糖尿病治療において患者のエンパワーメントと自己管理が重視されるようになっています。デジタル糖尿病管理ソリューションは、情報への容易なアクセス、個別化された洞察、モニタリングとアドヒアランスのためのツールを提供することで、患者が自分の健康を管理する力を与えます。さらに、各国政府は、ヘルスケア成果の向上と医療費削減のため、デジタル糖尿病管理を含むデジタルヘルスソリューションの導入を積極的に推進しています。奨励金や支援政策が市場の成長をさらに後押ししています。
デジタル糖尿病管理の市場動向と促進要因：
技術の進歩
スマートフォン、ウェアラブルデバイス、インターネット接続の登場は、患者とヘルスケアプロバイダーの糖尿病管理方法に革命をもたらしました。これらの進歩により、血糖値や運動量などのシームレスなデータ収集を容易にする、使いやすいモバイルアプリケーションやウェアラブルガジェットの開発が可能になっています。さらに、クラウドベースのプラットフォームが登場し、患者の健康データをリアルタイムで安全に保存・分析できるようになっています。データ分析と人工知能の統合により、個別化された洞察と予測分析が提供され、患者が糖尿病管理について十分な情報に基づいた意思決定を行えるようになることで、これらのソリューションの機能がさらに強化されています。全体として、技術の進歩はデジタル糖尿病管理ツールの有効性とアクセシビリティを大幅に改善し、現代ヘルスケアに不可欠な要素となっています。
自己管理に対する意識の高まり
デジタル糖尿病管理ソリューションは、この動向を促進する上で重要な役割を果たしています。これらのツールは、患者が自分の健康状態や生活習慣を独自にモニターする能力を提供し、自分の状態をコントロールする感覚を与えます。直感的なインターフェースと教育リソースを通じて、デジタルプラットフォームは、食事選択、運動習慣、服薬アドヒアランスなどの糖尿病管理について患者を教育します。患者が積極的にケアに参加することで、これらのソリューションは治療コンプライアンスと全体的な健康アウトカムを改善します。さらに、デジタル・プラットフォームを通じて健康データにアクセスしたりヘルスケア・プロバイダーとコミュニケーションを取ったりできる利便性は、患者の関与を高め、糖尿病管理へのより協力的なアプローチにつながります。
政府の積極的な取り組み
世界各国の政府は、ヘルスケアの提供とアウトカムの改善におけるデジタルヘルス・ソリューションの潜在的な利点を認識しています。その結果、デジタル糖尿病管理やその他のデジタルヘルス技術の導入を支援するためのさまざまな取り組みや政策が実施されています。革新的なデジタル糖尿病管理ソリューションの開発と展開を奨励するために、ヘルスケア機関やテクノロジー企業に対してインセンティブ、補助金、助成金が提供されています。さらに、これらの技術の安全性と有効性を確保するための規制の枠組みも確立されています。こうした支援策により、市場成長のための環境が整えられ、投資が誘致され、イノベーションが促進されています。その結果、世界のデジタル糖尿病管理市場は大幅な拡大を遂げ、この分野の進歩を推進するために官民間の協力が増加しています。
本レポートで扱う主な質問
- 世界のデジタル糖尿病管理市場はこれまでどのように推移し、今後数年間はどのように推移するのか？
- 世界のデジタル糖尿病管理市場における促進要因、市場抑制要因、機会は何か？
- それぞれの促進要因、抑制要因、機会が世界のデジタル糖尿病管理市場に与える影響は？
- 主要な地域市場は？
- 最も魅力的なデジタル糖尿病管理市場を代表する国は？
- 製品タイプ別の市場内訳は？
- デジタル糖尿病管理市場で最も魅力的な製品タイプは？
- デバイスタイプ別の市場内訳は？
- デジタル糖尿病管理市場で最も魅力的なデバイスタイプは？
- 世界のデジタル糖尿病管理市場の競合構造は？
- 世界のデジタル糖尿病管理市場における主要プレイヤー/企業は？
目次
第1章 序文
第2章 調査範囲と調査手法
- 調査目的
- 利害関係者
- データソース
- 一次情報
- 二次情報
- 市場推定
- ボトムアップアプローチ
- トップダウンアプローチ
- 調査手法
第3章 エグゼクティブサマリー
第4章 イントロダクション
- 概要
- 主要産業動向
第5章 世界のデジタル糖尿病管理市場
- 市場概要
- 市場実績
- COVID-19の影響
- 市場予測
第6章 市場内訳：製品タイプ別
- スマートグルコースメーター
- 市場動向
- 市場予測
- スマートインスリンポンプ
- 市場動向
- 市場予測
- スマートインスリンペン
- 市場動向
- 市場予測
- アプリ
- 市場動向
- 市場予測
第7章 市場内訳：デバイスタイプ別
- ハンドヘルドデバイス
- 市場動向
- 市場予測
- ウェアラブルデバイス
- 市場動向
- 市場予測
第8章 市場内訳：地域別
- 北米
- 米国
- 市場動向
- 市場予測
- カナダ
- 市場動向
- 市場予測
- 米国
- アジア太平洋
- 中国
- 市場動向
- 市場予測
- 日本
- 市場動向
- 市場予測
- インド
- 市場動向
- 市場予測
- 韓国
- 市場動向
- 市場予測
- オーストラリア
- 市場動向
- 市場予測
- インドネシア
- 市場動向
- 市場予測
- その他
- 市場動向
- 市場予測
- 中国
- 欧州
- ドイツ
- 市場動向
- 市場予測
- フランス
- 市場動向
- 市場予測
- 英国
- 市場動向
- 市場予測
- イタリア
- 市場動向
- 市場予測
- スペイン
- 市場動向
- 市場予測
- ロシア
- 市場動向
- 市場予測
- その他
- 市場動向
- 市場予測
- ドイツ
- ラテンアメリカ
- ブラジル
- 市場動向
- 市場予測
- メキシコ
- 市場動向
- 市場予測
- その他
- 市場動向
- 市場予測
- ブラジル
- 中東・アフリカ地域
- 市場動向
- 市場内訳：国別
- 市場予測
第9章 SWOT分析
- 概要
- 強み
- 弱み
- 機会
- 脅威
第10章 バリューチェーン分析
第11章 ポーターのファイブフォース分析
- 概要
- 買い手の交渉力
- 供給企業の交渉力
- 競合の程度
- 新規参入業者の脅威
- 代替品の脅威
第12章 価格分析
第13章 競合情勢
- 市場構造
- 主要企業
- 主要企業のプロファイル
- Abbott Laboratories
- ACON Laboratories Inc
- Ascensia Diabetes Care Holdings AG（PHC Holdings Corporation）
- Becton, Dickinson and Company
- Dexcom Inc.
- F. Hoffmann-La Roche AG
- Medtronic plc
- Novo Nordisk A/S
- Tandem Diabetes Care Inc.
- Terumo Corporation
List of Figures
- Figure 1: Global: Digital Diabetes Management Market: Major Drivers and Challenges
- Figure 2: Global: Digital Diabetes Management Market: Sales Value (in Billion US$), 2017-2022
- Figure 3: Global: Digital Diabetes Management Market Forecast: Sales Value (in Billion US$), 2023-2028
- Figure 4: Global: Digital Diabetes Management Market: Breakup by Product Type (in %), 2022
- Figure 5: Global: Digital Diabetes Management Market: Breakup by Device Type (in %), 2022
- Figure 6: Global: Digital Diabetes Management Market: Breakup by Region (in %), 2022
- Figure 7: Global: Digital Diabetes Management (Smart Glucose Meter) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 8: Global: Digital Diabetes Management (Smart Glucose Meter) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 9: Global: Digital Diabetes Management (Smart Insulin Pumps) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 10: Global: Digital Diabetes Management (Smart Insulin Pumps) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 11: Global: Digital Diabetes Management (Smart Insulin Pens) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 12: Global: Digital Diabetes Management (Smart Insulin Pens) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 13: Global: Digital Diabetes Management (Apps) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 14: Global: Digital Diabetes Management (Apps) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 15: Global: Digital Diabetes Management (Handheld Devices) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 16: Global: Digital Diabetes Management (Handheld Devices) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 17: Global: Digital Diabetes Management (Wearable Devices) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 18: Global: Digital Diabetes Management (Wearable Devices) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 19: North America: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
- Figure 20: North America: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 21: United States: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
- Figure 22: United States: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 23: Canada: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
- Figure 24: Canada: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 25: Asia-Pacific: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
- Figure 26: Asia-Pacific: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 27: China: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
- Figure 28: China: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 29: Japan: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
- Figure 30: Japan: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 31: India: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
- Figure 32: India: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 33: South Korea: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
- Figure 34: South Korea: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 35: Australia: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
- Figure 36: Australia: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 37: Indonesia: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
- Figure 38: Indonesia: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 39: Others: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
- Figure 40: Others: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 41: Europe: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
- Figure 42: Europe: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 43: Germany: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
- Figure 44: Germany: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 45: France: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
- Figure 46: France: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 47: United Kingdom: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
- Figure 48: United Kingdom: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 49: Italy: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
- Figure 50: Italy: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 51: Spain: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
- Figure 52: Spain: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 53: Russia: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
- Figure 54: Russia: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 55: Others: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
- Figure 56: Others: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 57: Latin America: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
- Figure 58: Latin America: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 59: Brazil: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
- Figure 60: Brazil: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 61: Mexico: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
- Figure 62: Mexico: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 63: Others: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
- Figure 64: Others: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 65: Middle East and Africa: Digital Diabetes Management Market: Sales Value (in Million US$), 2017 & 2022
- Figure 66: Middle East and Africa: Digital Diabetes Management Market: Breakup by Country (in %), 2022
- Figure 67: Middle East and Africa: Digital Diabetes Management Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 68: Global: Digital Diabetes Management Industry: SWOT Analysis
- Figure 69: Global: Digital Diabetes Management Industry: Value Chain Analysis
- Figure 70: Global: Digital Diabetes Management Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Digital Diabetes Management Market: Key Industry Highlights, 2022 and 2028
- Table 2: Global: Digital Diabetes Management Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
- Table 3: Global: Digital Diabetes Management Market Forecast: Breakup by Device Type (in Million US$), 2023-2028
- Table 4: Global: Digital Diabetes Management Market Forecast: Breakup by Region (in Million US$), 2023-2028
- Table 5: Global: Digital Diabetes Management Market: Competitive Structure
- Table 6: Global: Digital Diabetes Management Market: Key Players
Abstract
The global digital diabetes management market size reached US$ 10.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 36.0 Billion by 2028, exhibiting a growth rate (CAGR) of 22.2% during 2022-2028. The rising prevalence of diabetes, significant technological advancements, a shift toward patient-centric care, favorable government initiatives, AI integration, increasing adoption of telehealth and remote patient monitoring solutions, and strategic collaborations are some of the major factors propelling the market.
Digital diabetes management refers to the utilization of technology and digital solutions to assist individuals in monitoring and controlling their diabetes condition. These digital tools and applications offer various functionalities that aid in tracking blood glucose levels, medication adherence, physical activity, and dietary intake. By leveraging smartphones, wearable devices, and cloud-based platforms, digital diabetes management enables real-time data collection and analysis, fostering better self-management and engagement for patients. One of the key advantages of digital diabetes management is its ability to provide personalized insights and actionable recommendations based on the data collected. This empowers patients to make informed decisions about their lifestyle choices and treatment plans. Additionally, healthcare providers can access a comprehensive view of the patient's health, allowing for remote monitoring and timely interventions when necessary. Furthermore, these technologies contribute to better patient outcomes by promoting continuous engagement and motivation through interactive features and educational resources. They also facilitate seamless communication between patients and healthcare professionals, enhancing the overall care experience.
The rising prevalence of diabetes worldwide has created a significant demand for effective and convenient solutions to manage the condition. Digital diabetes management tools offer real-time monitoring and personalized care, making them attractive options for patients and healthcare providers alike. Additionally, there is a growing emphasis on patient empowerment and self-management in diabetes care. Digital diabetes management solutions empower patients to take control of their health by providing easy access to information, personalized insights, and tools for monitoring and adherence. Other than this, the integration of artificial intelligence and machine learning algorithms into digital diabetes management platforms has enabled predictive analysis and personalized recommendations. These technologies enhance treatment plans and interventions, driving market demand. Besides this, the increasing adoption of telehealth and remote patient monitoring solutions has further fueled the demand for digital diabetes management tools. These technologies enable healthcare providers to remotely monitor patients' health and intervene when necessary, improving patient care and convenience. In line with this, the market has witnessed collaborations between digital health companies and pharmaceutical firms, leading to the integration of diabetes management solutions with medication and treatment regimens. Such partnerships expand the market reach and enhance product offerings. Furthermore, there is a growing emphasis on patient empowerment and self-management in diabetes care. Digital diabetes management solutions empower patients to take control of their health by providing easy access to information, personalized insights, and tools for monitoring and adherence. Moreover, governments in various countries are actively promoting the adoption of digital health solutions, including digital diabetes management, to improve healthcare outcomes and reduce healthcare costs. Incentives and supportive policies have further boosted the market's growth.
Digital Diabetes Management Market Trends/Drivers:
Technological Advancements
The advent of smartphones, wearable devices, and internet connectivity has revolutionized the way patients and healthcare providers manage diabetes. These advancements have enabled the development of user-friendly mobile applications and wearable gadgets that facilitate seamless data collection, such as blood glucose levels and physical activity. Additionally, cloud-based platforms have emerged, allowing secure storage and analysis of patients' health data in real-time. The integration of data analytics and artificial intelligence has further enhanced the capabilities of these solutions by providing personalized insights and predictive analysis, empowering patients to make informed decisions about their diabetes management. Overall, technological advancements have significantly improved the effectiveness and accessibility of digital diabetes management tools, making them an integral part of modern healthcare.
Growing Awareness About Self-Management
Digital diabetes management solutions have played a crucial role in promoting this trend. These tools offer patients the ability to monitor their health and lifestyle habits independently, providing them with a sense of control over their condition. Through intuitive interfaces and educational resources, digital platforms educate patients about diabetes management, including dietary choices, exercise routines, and medication adherence. By actively involving patients in their care, these solutions improve treatment compliance and overall health outcomes. Additionally, the convenience of accessing health data and communicating with healthcare providers through digital platforms fosters greater patient engagement, leading to a more collaborative approach to diabetes management.
Favorable Government Initiatives
Governments worldwide have recognized the potential benefits of digital health solutions in improving healthcare delivery and outcomes. Consequently, they have implemented various initiatives and policies to support the adoption of digital diabetes management and other digital health technologies. Incentives, subsidies, and grants have been provided to healthcare organizations and technology companies to encourage the development and deployment of innovative digital diabetes management solutions. Moreover, regulatory frameworks have been established to ensure the safety and efficacy of these technologies. These supportive measures have created a conducive environment for market growth, attracting investment and fostering innovation. As a result, the global digital diabetes management market has experienced significant expansion, with increasing collaborations between public and private sectors to drive advancements in this domain.
Digital Diabetes Management Industry Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global digital diabetes management market report, along with forecasts at the global, regional and country levels from 2023-2028. Our report has categorized the market based on product type and device type.
Breakup by Product Type:
Smart Glucose Meter
Smart Insulin Pumps
Smart Insulin Pens
Apps
Smart glucose meter dominates the market
The report has provided a detailed breakup and analysis of the market based on the product type. This includes smart glucose meter, smart insulin pumps, smart insulin pens, and apps. According to the report, smart glucose meter represented the largest segment.
Smart glucose meters offer advanced features and connectivity options that cater to the growing demand for technologically sophisticated diabetes management solutions. These devices can seamlessly sync with smartphones and other digital platforms, allowing users to access their real-time blood glucose data conveniently. Additionally, the rising prevalence of diabetes worldwide has led to an increased demand for accurate and user-friendly glucose monitoring devices. Smart glucose meters provide precise readings, reducing the risk of errors in diabetes management and enhancing patient compliance with treatment plans. Other than this, the emphasis on self-management and patient empowerment in diabetes care has further boosted the popularity of smart glucose meters. These devices enable individuals to track their glucose levels independently, promoting a proactive approach to diabetes management and fostering a sense of control over the condition. Moreover, healthcare providers are increasingly adopting telehealth and remote monitoring solutions, and smart glucose meters align well with this trend. The ability to remotely transmit data to healthcare professionals facilitates timely interventions and personalized care, making these devices indispensable tools in modern diabetes management.
Breakup by Device Type:
Handheld Devices
Wearable Devices
Wearable devices hold the largest share in the market
A detailed breakup and analysis of the market based on the device type has also been provided in the report. This includes handheld devices and wearable devices. According to the report, wearable devices accounted for the largest market share.
Wearable devices offer a seamless and non-intrusive way to monitor various health parameters, making them highly attractive to individuals seeking continuous health tracking without disruption to their daily routines. In the context of diabetes management, wearable devices equipped with sensors can monitor blood glucose levels, physical activity, heart rate, and other relevant data. Additionally, the increasing prevalence of chronic diseases, including diabetes, has driven the demand for personalized and proactive healthcare solutions. Wearable devices enable real-time data collection and analysis, providing users with valuable insights into their health status and progress in managing their condition. Other than this, wearable devices have witnessed remarkable technological advancements, enhancing their accuracy, functionality, and overall user experience. These innovations have broadened the scope of wearable devices, making them versatile tools that cater to diverse healthcare needs, including diabetes management. Furthermore, the integration of wearable devices with smartphones and other digital platforms has facilitated seamless data sharing, communication with healthcare providers, and integration with other digital health applications. This connectivity has further enhanced the value of wearable devices in the healthcare ecosystem. Moreover, the growing focus on preventive healthcare and wellness has fueled the adoption of wearable devices by health-conscious individuals, making them a mainstream trend. The combination of convenience, personalized insights, technological advancements, and the shift towards proactive health management has propelled wearable devices to become the largest segment in the market for digital health devices, including those designed for diabetes management.
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America exhibits a clear dominance in the market
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for digital diabetes management.
North America has a high prevalence of diabetes, with both type 1 and type 2 diabetes affecting a significant portion of the population. This substantial patient pool has created a strong demand for innovative and effective diabetes management solutions, including digital technologies. Additionally, the region has a well-developed healthcare infrastructure and advanced technological capabilities. The region is at the forefront of digital health adoption, with extensive usage of smartphones, wearables, and telehealth platforms. This technological readiness has facilitated the integration and adoption of digital diabetes management tools across healthcare systems and patient populations. Furthermore, favorable government policies and initiatives promoting digital health adoption have further accelerated the growth of the market. These policies include incentives for healthcare providers to adopt digital solutions, reimbursement support for telehealth services, and regulatory frameworks that encourage innovation in digital health technologies. Moreover, the presence of major players and tech-savvy startups in the digital health industry within North America has contributed to a vibrant and competitive market. These companies have invested in research and development, resulting in a wide range of cutting-edge digital diabetes management solutions that cater to various patient needs.
Competitive Landscape:
Major players in the market have invested heavily in research and development to advance the capabilities of digital diabetes management solutions. They continuously upgrade their smart glucose meters, wearable devices, mobile applications, and cloud-based platforms to provide users with enhanced functionalities, improved accuracy, and better user experiences. Integration of artificial intelligence, machine learning, and data analytics into these solutions has enabled personalized insights, predictive analysis, and more effective treatment recommendations. Additionally, key players have formed collaborations and partnerships with various stakeholders to expand their market reach and enhance product offerings. These partnerships often involve pharmaceutical companies, healthcare providers, and telehealth platforms. By integrating their digital diabetes management solutions with medication regimens, electronic health records, and telemedicine services, these companies can offer comprehensive and seamless healthcare experiences for individuals with diabetes. Other than this, understanding the importance of patient engagement and empowerment in diabetes care, key players have focused on developing user-friendly and patient-centric solutions. They prioritize user experience, offering intuitive interfaces, educational resources, and personalized coaching to encourage self-management and lifestyle changes. The goal is to foster long-term engagement and adherence to treatment plans, leading to improved health outcomes for patients. Besides this, recognizing the sensitivity of health data, major players have placed a strong emphasis on data security and privacy. They comply with regulatory standards such as HIPAA (Health Insurance Portability and Accountability Act) and GDPR (General Data Protection Regulation) to ensure the safe storage and transmission of patient information. This commitment to data security builds trust among users and healthcare professionals, further driving the adoption of their digital diabetes management solutions.
The market research report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:
Abbott Laboratories
ACON Laboratories Inc
Ascensia Diabetes Care Holdings AG (PHC Holdings Corporation)
Becton, Dickinson and Company
Dexcom Inc.
F. Hoffmann-La Roche AG
Medtronic plc
Novo Nordisk A/S
Tandem Diabetes Care Inc.
Terumo Corporation
Recent Developments:
Novo Nordisk A/S and Aspect Biosystems, two prominent players in the biotechnology and pharmaceutical industries, recently announced a strategic partnership with the shared objective of advancing the development of bioprinted tissue therapeutics tailored to address the challenges of diabetes and obesity. This collaboration represents a significant step forward in the field of regenerative medicine and holds promising potential for patients suffering from these chronic metabolic disorders.
Tandem Diabetes Care Inc. recently announced the results of a significant meta-analysis involving their Control-IQ technology. This comprehensive study demonstrates the positive clinical impact of automatic correction bolusing on glucose control in individuals with Type 1 diabetes, representing a substantial advancement in diabetes care.
Terumo Corporation and Glooko, a prominent digital health platform specializing in diabetes management, have jointly announced a collaboration aimed at developing a new and innovative solution for diabetes data sharing. This partnership brings together Terumo's expertise in medical devices and Glooko's proficiency in digital health technologies, with the ultimate goal of enhancing diabetes care through improved data accessibility and connectivity.
Key Questions Answered in This Report:
- How has the global digital diabetes management market performed so far, and how will it perform in the coming years?
- What are the drivers, restraints, and opportunities in the global digital diabetes management market?
- What is the impact of each driver, restraint, and opportunity on the global digital diabetes management market?
- What are the key regional markets?
- Which countries represent the most attractive digital diabetes management market?
- What is the breakup of the market based on the product type?
- Which is the most attractive product type in the digital diabetes management market?
- What is the breakup of the market based on the device type?
- Which is the most attractive device type in the digital diabetes management market?
- What is the competitive structure of the global digital diabetes management market?
- Who are the key players/companies in the global digital diabetes management market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Digital Diabetes Management Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product Type
- 6.1 Smart Glucose Meter
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Smart Insulin Pumps
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Smart Insulin Pens
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Apps
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
7 Market Breakup by Device Type
- 7.1 Handheld Devices
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Wearable Devices
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
8 Market Breakup by Region
- 8.1 North America
- 8.1.1 United States
- 8.1.1.1 Market Trends
- 8.1.1.2 Market Forecast
- 8.1.2 Canada
- 8.1.2.1 Market Trends
- 8.1.2.2 Market Forecast
- 8.1.1 United States
- 8.2 Asia-Pacific
- 8.2.1 China
- 8.2.1.1 Market Trends
- 8.2.1.2 Market Forecast
- 8.2.2 Japan
- 8.2.2.1 Market Trends
- 8.2.2.2 Market Forecast
- 8.2.3 India
- 8.2.3.1 Market Trends
- 8.2.3.2 Market Forecast
- 8.2.4 South Korea
- 8.2.4.1 Market Trends
- 8.2.4.2 Market Forecast
- 8.2.5 Australia
- 8.2.5.1 Market Trends
- 8.2.5.2 Market Forecast
- 8.2.6 Indonesia
- 8.2.6.1 Market Trends
- 8.2.6.2 Market Forecast
- 8.2.7 Others
- 8.2.7.1 Market Trends
- 8.2.7.2 Market Forecast
- 8.2.1 China
- 8.3 Europe
- 8.3.1 Germany
- 8.3.1.1 Market Trends
- 8.3.1.2 Market Forecast
- 8.3.2 France
- 8.3.2.1 Market Trends
- 8.3.2.2 Market Forecast
- 8.3.3 United Kingdom
- 8.3.3.1 Market Trends
- 8.3.3.2 Market Forecast
- 8.3.4 Italy
- 8.3.4.1 Market Trends
- 8.3.4.2 Market Forecast
- 8.3.5 Spain
- 8.3.5.1 Market Trends
- 8.3.5.2 Market Forecast
- 8.3.6 Russia
- 8.3.6.1 Market Trends
- 8.3.6.2 Market Forecast
- 8.3.7 Others
- 8.3.7.1 Market Trends
- 8.3.7.2 Market Forecast
- 8.3.1 Germany
- 8.4 Latin America
- 8.4.1 Brazil
- 8.4.1.1 Market Trends
- 8.4.1.2 Market Forecast
- 8.4.2 Mexico
- 8.4.2.1 Market Trends
- 8.4.2.2 Market Forecast
- 8.4.3 Others
- 8.4.3.1 Market Trends
- 8.4.3.2 Market Forecast
- 8.4.1 Brazil
- 8.5 Middle East and Africa
- 8.5.1 Market Trends
- 8.5.2 Market Breakup by Country
- 8.5.3 Market Forecast
9 SWOT Analysis
- 9.1 Overview
- 9.2 Strengths
- 9.3 Weaknesses
- 9.4 Opportunities
- 9.5 Threats
10 Value Chain Analysis
11 Porters Five Forces Analysis
- 11.1 Overview
- 11.2 Bargaining Power of Buyers
- 11.3 Bargaining Power of Suppliers
- 11.4 Degree of Competition
- 11.5 Threat of New Entrants
- 11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
- 13.1 Market Structure
- 13.2 Key Players
- 13.3 Profiles of Key Players
- 13.3.1 Abbott Laboratories
- 13.3.1.1 Company Overview
- 13.3.1.2 Product Portfolio
- 13.3.1.3 Financials
- 13.3.1.4 SWOT Analysis
- 13.3.2 ACON Laboratories Inc
- 13.3.2.1 Company Overview
- 13.3.2.2 Product Portfolio
- 13.3.3 Ascensia Diabetes Care Holdings AG (PHC Holdings Corporation)
- 13.3.3.1 Company Overview
- 13.3.3.2 Product Portfolio
- 13.3.4 Becton, Dickinson and Company
- 13.3.4.1 Company Overview
- 13.3.4.2 Product Portfolio
- 13.3.4.3 Financials
- 13.3.4.4 SWOT Analysis
- 13.3.5 Dexcom Inc.
- 13.3.5.1 Company Overview
- 13.3.5.2 Product Portfolio
- 13.3.5.3 Financials
- 13.3.5.4 SWOT Analysis
- 13.3.6 F. Hoffmann-La Roche AG
- 13.3.6.1 Company Overview
- 13.3.6.2 Product Portfolio
- 13.3.6.3 SWOT Analysis
- 13.3.7 Medtronic plc
- 13.3.7.1 Company Overview
- 13.3.7.2 Product Portfolio
- 13.3.7.3 Financials
- 13.3.7.4 SWOT Analysis
- 13.3.8 Novo Nordisk A/S
- 13.3.8.1 Company Overview
- 13.3.8.2 Product Portfolio
- 13.3.8.3 Financials
- 13.3.8.4 SWOT Analysis
- 13.3.9 Tandem Diabetes Care Inc.
- 13.3.9.1 Company Overview
- 13.3.9.2 Product Portfolio
- 13.3.9.3 Financials
- 13.3.10 Terumo Corporation
- 13.3.10.1 Company Overview
- 13.3.10.2 Product Portfolio
- 13.3.10.3 Financials
- 13.3.10.4 SWOT Analysis
- 13.3.1 Abbott Laboratories
